vs
Side-by-side financial comparison of Allegion (ALLE) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Allegion). Allegion runs the higher net margin — 13.4% vs 7.3%, a 6.1% gap on every dollar of revenue. On growth, Allegion posted the faster year-over-year revenue change (9.7% vs 4.8%). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 3.5%).
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ALLE vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.3B |
| Net Profit | $138.1M | $97.3M |
| Gross Margin | 44.0% | 14.9% |
| Operating Margin | 18.9% | 83.4% |
| Net Margin | 13.4% | 7.3% |
| Revenue YoY | 9.7% | 4.8% |
| Net Profit YoY | -6.8% | -42.0% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | $1.3B | ||
| Q4 25 | $1.0B | $339.0M | ||
| Q3 25 | $1.1B | $327.3M | ||
| Q2 25 | $1.0B | $321.4M | ||
| Q1 25 | $941.9M | $330.6M | ||
| Q4 24 | $945.6M | $348.5M | ||
| Q3 24 | $967.1M | $345.5M | ||
| Q2 24 | $965.6M | $336.2M |
| Q1 26 | $138.1M | $97.3M | ||
| Q4 25 | $147.5M | $44.7M | ||
| Q3 25 | $188.4M | $38.7M | ||
| Q2 25 | $159.7M | $34.0M | ||
| Q1 25 | $148.2M | $58.0M | ||
| Q4 24 | $144.1M | $37.5M | ||
| Q3 24 | $174.2M | $33.8M | ||
| Q2 24 | $155.4M | $38.4M |
| Q1 26 | 44.0% | 14.9% | ||
| Q4 25 | 44.5% | 59.7% | ||
| Q3 25 | 45.8% | 59.5% | ||
| Q2 25 | 45.6% | 59.8% | ||
| Q1 25 | 44.9% | 58.4% | ||
| Q4 24 | 44.1% | 55.5% | ||
| Q3 24 | 44.7% | 54.2% | ||
| Q2 24 | 44.4% | 52.0% |
| Q1 26 | 18.9% | 83.4% | ||
| Q4 25 | 20.3% | 19.9% | ||
| Q3 25 | 21.8% | 17.9% | ||
| Q2 25 | 21.5% | 16.8% | ||
| Q1 25 | 20.9% | 21.6% | ||
| Q4 24 | 19.5% | 16.9% | ||
| Q3 24 | 22.2% | 15.0% | ||
| Q2 24 | 21.6% | 11.8% |
| Q1 26 | 13.4% | 7.3% | ||
| Q4 25 | 14.3% | 13.2% | ||
| Q3 25 | 17.6% | 11.8% | ||
| Q2 25 | 15.6% | 10.6% | ||
| Q1 25 | 15.7% | 17.5% | ||
| Q4 24 | 15.2% | 10.8% | ||
| Q3 24 | 18.0% | 9.8% | ||
| Q2 24 | 16.1% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $0.95 | ||
| Q3 25 | $2.18 | $0.81 | ||
| Q2 25 | $1.85 | $0.70 | ||
| Q1 25 | $1.71 | $1.17 | ||
| Q4 24 | $1.65 | $0.74 | ||
| Q3 24 | $1.99 | $0.66 | ||
| Q2 24 | $1.77 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $308.9M | $245.4M |
| Total DebtLower is stronger | $2.0B | $1.2B |
| Stockholders' EquityBook value | $2.1B | $796.3M |
| Total Assets | $5.3B | $2.4B |
| Debt / EquityLower = less leverage | 0.97× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $308.9M | $245.4M | ||
| Q4 25 | $356.2M | $363.4M | ||
| Q3 25 | $302.7M | $296.4M | ||
| Q2 25 | $656.8M | $292.9M | ||
| Q1 25 | $494.5M | $306.8M | ||
| Q4 24 | $503.8M | $320.8M | ||
| Q3 24 | $878.9M | $299.3M | ||
| Q2 24 | $747.5M | $344.4M |
| Q1 26 | $2.0B | $1.2B | ||
| Q4 25 | $2.0B | $1.2B | ||
| Q3 25 | $2.1B | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.0B | $1.2B | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $2.1B | $796.3M | ||
| Q4 25 | $2.1B | $911.5M | ||
| Q3 25 | $1.9B | $849.2M | ||
| Q2 25 | $1.8B | $882.3M | ||
| Q1 25 | $1.6B | $820.8M | ||
| Q4 24 | $1.5B | $906.9M | ||
| Q3 24 | $1.6B | $878.9M | ||
| Q2 24 | $1.4B | $905.4M |
| Q1 26 | $5.3B | $2.4B | ||
| Q4 25 | $5.2B | $2.5B | ||
| Q3 25 | $5.2B | $2.4B | ||
| Q2 25 | $4.9B | $2.5B | ||
| Q1 25 | $4.6B | $2.5B | ||
| Q4 24 | $4.5B | $2.5B | ||
| Q3 24 | $5.0B | $2.5B | ||
| Q2 24 | $4.8B | $2.5B |
| Q1 26 | 0.97× | 1.53× | ||
| Q4 25 | 0.96× | 1.34× | ||
| Q3 25 | 1.07× | 1.44× | ||
| Q2 25 | 1.16× | 1.39× | ||
| Q1 25 | 1.24× | 1.49× | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 1.69× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $101.3M | $293.2M |
| Free Cash FlowOCF − Capex | — | $209.9M |
| FCF MarginFCF / Revenue | — | 15.7% |
| Capex IntensityCapex / Revenue | 2.0% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.73× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $101.3M | $293.2M | ||
| Q4 25 | $240.1M | $93.6M | ||
| Q3 25 | $229.5M | $111.3M | ||
| Q2 25 | $209.7M | $17.4M | ||
| Q1 25 | $104.5M | $116.6M | ||
| Q4 24 | $219.0M | $43.8M | ||
| Q3 24 | $231.9M | $48.8M | ||
| Q2 24 | $173.0M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $200.5M | $87.2M | ||
| Q3 25 | $209.8M | $106.3M | ||
| Q2 25 | $192.0M | $13.6M | ||
| Q1 25 | $83.4M | $100.9M | ||
| Q4 24 | $194.9M | $35.2M | ||
| Q3 24 | $212.0M | $39.4M | ||
| Q2 24 | $152.1M | $-33.1M |
| Q1 26 | — | 15.7% | ||
| Q4 25 | 19.4% | 25.7% | ||
| Q3 25 | 19.6% | 32.5% | ||
| Q2 25 | 18.8% | 4.2% | ||
| Q1 25 | 8.9% | 30.5% | ||
| Q4 24 | 20.6% | 10.1% | ||
| Q3 24 | 21.9% | 11.4% | ||
| Q2 24 | 15.8% | -9.8% |
| Q1 26 | 2.0% | 2.5% | ||
| Q4 25 | 3.8% | 1.9% | ||
| Q3 25 | 1.8% | 1.5% | ||
| Q2 25 | 1.7% | 1.2% | ||
| Q1 25 | 2.2% | 4.7% | ||
| Q4 24 | 2.5% | 2.5% | ||
| Q3 24 | 2.1% | 2.7% | ||
| Q2 24 | 2.2% | 1.7% |
| Q1 26 | 0.73× | 3.01× | ||
| Q4 25 | 1.63× | 2.09× | ||
| Q3 25 | 1.22× | 2.88× | ||
| Q2 25 | 1.31× | 0.51× | ||
| Q1 25 | 0.71× | 2.01× | ||
| Q4 24 | 1.52× | 1.17× | ||
| Q3 24 | 1.33× | 1.44× | ||
| Q2 24 | 1.11× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
HAE
Segment breakdown not available.
